NHS England explores funding options for cystic fibrosis drug

NHS England is “committed to exploring and developing alternative routes” to enable people with cystic fibrosis to access Orkambi (ivacaftor-lumacaftor) on the NHS if Vertex, the US company that…


Read Original Article: NHS England explores funding options for cystic fibrosis drug »